Healthcare -
Drug Manufacturers - General - NYSE - DK
$ 90.65
1.6 %
$ 399 B
Market Cap
28.51
P/E
NVO - COST OF REVENUE
Cost of Revenue NVO - Novo Nordisk A/S
44.5 B
LAST VALUE
25.10%
2 YEAR CAGR
17.25%
5 YEAR CAGR
11.82%
10 YEAR CAGR